Literature DB >> 25791539

The first Clostridium difficile ribotype 027 strain isolated in Taiwan.

Mei-Ju Lai1, Tzong-Shi Chiueh2, Zheng-Yi Huang1, Jung-Chung Lin3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25791539     DOI: 10.1016/j.jfma.2015.02.006

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


× No keyword cloud information.
  5 in total

Review 1.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

2.  Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.

Authors:  M D Cairns; M D Preston; C L Hall; D N Gerding; P M Hawkey; H Kato; H Kim; E J Kuijper; T D Lawley; H Pituch; S Reid; B Kullin; T V Riley; K Solomon; P J Tsai; J S Weese; R A Stabler; B W Wren
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

3.  The First Two Clostridium difficile Ribotype 027/ST1 Isolates Identified in Beijing, China-an Emerging Problem or a Neglected Threat?

Authors:  Jing-Wei Cheng; Meng Xiao; Timothy Kudinha; Zhi-Peng Xu; Xin Hou; Lin-Ying Sun; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

4.  Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan.

Authors:  Haruo Suzuki; Masaru Tomita; Pei-Jane Tsai; Wen-Chien Ko; Yuan-Pin Hung; I-Hsiu Huang; Jenn-Wei Chen
Journal:  Gut Pathog       Date:  2017-11-29       Impact factor: 4.181

5.  Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan.

Authors:  Yuan-Pin Hung; Pei-Jane Tsai; Yuan-Ti Lee; Hung-Jen Tang; Hsiao-Ju Lin; Hsiu-Chuan Liu; Jen-Chieh Lee; Bo-Yang Tsai; Po-Ren Hsueh; Wen-Chien Ko
Journal:  Infect Drug Resist       Date:  2018-08-15       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.